Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Nobuo Sekiguchi"'
Autor:
Shumpei Ozawa, Satoshi Miki, Fumiaki Kimura, Yuji Kisaka, Yoshikazu Takahashi, Shinichi Tashiro, Nobuo Sekiguchi, Tomone Suwa, Manabu Tanaka
Publikováno v:
Metallurgical and Materials Transactions A. 52:5293-5299
TIG welding of high manganese stainless steels was conducted with different sulfur contents of 5 and 20 ppm. The penetration depth of the welding bead clearly increased even when the sulfur content of the sample was only very slightly increased from
Autor:
Hidetoshi Shindoh, Motohiro Kato, Nobuo Sekiguchi, Kenji Takanashi, Akihisa Kaneko, Keiichi Morita, Shunsuke Nagao, Masaki Ishigai
Publikováno v:
Xenobiotica. 47:1042-1051
1. A novel selective anaplastic lymphoma kinase (ALK) inhibitor, alectinib, has shown remarkable efficacy and safety in patients with ALK-positive non-small-cell lung cancer (NSCLC). The purpose of this study was to evaluate in vitro the potential to
Autor:
Tomone Suwa, Y. Takahashi, Y. Nabara, M. Oshikiri, K. Shibutani, Yoshihiko Nunoya, Nobuo Sekiguchi, Hidemitsu Matsuda, Fumiaki Tsutsumi
Publikováno v:
IEEE Transactions on Applied Superconductivity. 26:1-5
The International Thermonuclear Experimental Reactor (ITER) magnet system is composed of four kinds of large superconducting magnets. Those magnets are manufactured by using cable-in-conduit conductors (CICCs). In the production process of the CICCs,
Autor:
Chiyomi Kubo, Akira Takeiri, Futa Mimoto, Naoaki Murao, Shunsuke Ito, Shotaro Takata, Atsuhiko Maeda, Masaki Ishigai, Kumiko Muraoka, Yuki Iwayanagi, Ayako Takahashi, Nobuo Sekiguchi, Shuichi Chiba, Mariko Yano, Tetsuya Wakabayashi
Publikováno v:
mAbs. 10(8)
Immunogenicity is a key factor capable of influencing the efficacy and safety of therapeutic antibodies. A recently developed method called MHC-associated peptide proteomics (MAPPs) uses liquid chromatography/mass spectrometry to identify the peptide
Autor:
Y. Nabara, Yoshihiko Nunoya, Fumiaki Tsutsumi, O. Teshima, Y. Takahashi, Kunihiro Matsui, Y. Uno, K. Shibutani, Hidemasa Ozeki, M. Oshikiri, Nobuo Sekiguchi, Kiyoshi Okuno, Tsutomu Hemmi, Takaaki Isono, M. Kanaya, Tomone Suwa, K. Kawano
Publikováno v:
IEEE Transactions on Applied Superconductivity. 25:1-4
The Japan Atomic Energy Agency is responsible for procuring all amounts of central solenoid (CS) conductors for International Thermonuclear Experimental Reactor, including CS jacket sections. The conductor is cable-in-conduit conductor with a central
Autor:
Tomone Suwa, Hideki Kajitani, Tsutomu Hemmi, Takeru Sakurai, Yukinobu Murakami, Tsuyoshi Takano, Fumiaki Tsutsumi, Kiyoshi Okuno, Y. Takahashi, Y. Uno, Kunihiro Matsui, Hidemasa Ozeki, Takaaki Isono, M. Oshikiri, Norikiyo Koizumi, K. Shibutani, Nobuo Sekiguchi, Y. Nabara, Yoshihiko Nunoya, Hidemitsu Matsuda, Masahide Iguchi
Publikováno v:
IEEE Transactions on Applied Superconductivity. 25:1-5
We describe herein the characteristics of a Nb 3 Sn cable inserted into a conduit (cable-in-conduit conductor) for the International Thermonuclear Experimental Reactor toroidal field (TF) coil and central solenoid (CS). During insertion, the pulling
Autor:
Kazuki Shimizu, Tadakatsu Takahashi, Hideki Sato, Fumihiko Ichikawa, Shigeyuki Iijima, Suguru Harada, Nobuo Sekiguchi, Yoshiyuki Ono, Hirotaka Kashiwagi, Masaki Ishigai, Susumu Ito, Tsuyoshi Haneishi, Takamitsu Kobayashi
Publikováno v:
Bioorganic & Medicinal Chemistry. 19:4721-4729
Novel vitamin D3 analogs with carboxylic acid were explored, focusing on a nonsecosteroidal analog, LG190178, with a bisphenyl skeleton. From X-ray analysis of these analogs with vitamin D receptor (VDR), the carboxyl groups had very unique hydrogen
Autor:
Hiroo Watanabe, Tetsuya Mitsui, Motohiro Kato, Maiko Takada, Shotaro Takata, Nobuo Sekiguchi, Yoshinori Aso, Masaki Ishigai
Publikováno v:
Drug Metabolism and Disposition. 39:1255-1262
It was previously demonstrated that mibefradil, which shows mechanism-based inhibition in humans, also caused drug-drug interactions (DDIs) with midazolam (MDZ) in rats. In this study, we aimed to quantitatively predict the DDIs observed in rats usin
Autor:
Yoshinori Aso, Masaki Ishigai, Kenji Takanashi, Motohiro Kato, Tetsuya Mitsui, Nobuo Sekiguchi, Atsuko Higashida, Yoshiaki Nabuchi
Publikováno v:
Drug Metabolism and Pharmacokinetics. 24:500-510
Summary: A method of assessing the risk of drug-drug interaction (DDI) caused by mechanism-based inhibition (MBI) was developed for early-stage drug development using cytochrome P450 (CYP) 3A4 inhibition screening data. CYP3A4 inhibition was evaluate
Autor:
Motohiro Kato, H. Watanabe, Yoshinori Aso, Maiko Takada, Masaki Ishigai, Atsuko Higashida, S. Sakai, Nobuo Sekiguchi
Publikováno v:
Xenobiotica. 38:368-381
1. There have been no reports showing that the area under the concentration-time curve (AUC) of a probe drug is elevated due to mechanism-based inhibition (MBI) of drug-metabolizing enzymes in animals. This study ascertained that mechanism-based inhi